Drugs Information:
Lixisenatide
Basic Information
|
||
ID | DDInter1082 | |
Drug Type | biotech | |
Protein Chemical Formula | None | |
Protein Average Weight | - | |
CAS Number | 320367-13-3 | |
Description | Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes mellitus (T2DM). It is sold under the brand name Adlyxin by Sanofi-Aventis. Adlyxin recieved FDA approval July 28, 2016 [L763]. | |
ATC Classification | A10AE54 A10BJ03 | |
Sequences | > Lixisenatide Sequence HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPSKKKKKK | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider Wikipedia ChEMBL |
Interactions with
Lixisenatide
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|